Eisai Withdraws Application for Additional Indication of Aricept for Treatment of Severe Alzheimer's Disease in Europe
The Aricept®'s indication in the treatment of severe Alzheimer's disease has already been approved in the USA, India, New Zealand and Philippines. In addition, the application has been submitted in Japan.
Eisai will continue to undertake activities to help patients who are suffering from Alzheimer's disease.
Corporate Communications Department
Eisai Co., Ltd.
Posted: April 2007
Recommended for you